Please login to the form below
Oncodesign
This page shows the latest Oncodesign news and features for those working in and with pharma, biotech and healthcare.
Latest Intelligence
-
Deal Watch January 2016
Staying with oncology, BMS has entered a collaboration with Oncodesign for the development and commercialisation of novel macrocyclin compounds. ... Oncodesign will receive a $3m upfront and will undertake to lead optimisation work with BMS taking over
-
Pharma deals during September 2012
Baxter has an existing equity investment of $50m in Onconova. In a couple of earlier stage deals, Sanofi and Oncodesign have entered into a research collaboration and licence agreement to use ... The Nanocyclix platform will be exclusively applied in
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Business Development Director – Health Education
-
excellent commission
-
Senior Account Manager
-
Competitive Salary Offered
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
- Account Manager- Healthcare Advertising
-
Negotiable
- Account Manager- Healthcare Advertising
-
Negotiable
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Associate Director
-
£75, 000-90, 000
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Systematic Reviewer - Oxford
-
Negotiable
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
-
Business Director
-
Competitive Salary Offered
-
Account Manager
-
Negotiable
-
Account Director
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- Beneluxa: the future of European market access?
- Fishawack acquires Blue Latitude Health
- FDA clears Sandoz and Pear’s Opioid Use Disorder app
- As May delays, industry warns again of ‘no-deal’ Brexit
- Clark Health Communications and Egg digital announce new collaboration
- Axovant drops last ‘legacy’ drug to focus on gene therapies
PMHub
wethepeople
wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...
Latest intelligence
- Report: Achieving launch excellence in the challenging healthcare markets of today
- Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
- What is blockchain and why should i care - Richard Springham
- Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
- NHS medicines optimisation milestone
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Quick links
Infographics
